IVF (invobioscience.com) Market Value to Book Value Ratio

The ratio of INVO Fertility Inc (IVF) current market price to its net book value demonstrates a stable trend, where the 0.09 mark indicates the business valuation level. INVO Fertility Inc (IVF) is advancing IVF automation through INVOcell incubators. Demand for services is moderately dependent on economic cycles, while environmental policy relies on clean production standards and energy efficiency.

IVF - INVO Fertility Corp Market-to-Book Ratio over the range 04/29/2025 - 10/28/2026

IVF (INVO Bioscience): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Chart INVO Fertility Inc|IVF - Analyst Median Target
- market capitalization data:
Market Value INVO Bioscience, Inc.|IVF - Full Business Value
- book capitalization data:
Book Value per Share INVO Fertility|IVF - Total Stockholders' Equity|Market Capitalization to Book Value Ratio invobioscience.com|IVF - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital INVO Fertility Inc|IVF - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital INVO Bioscience, Inc.|IVF - Company Aggregate Debts|Debt to Book Capitalization Ratio INVO Bioscience, Inc.|IVF - Company Long-Term Debt|Company Short-Term Debts INVO Fertility
Fundamental valuation:INVO Fertility Inc

The promotion of the INVOcell system and the expansion of the IVF clinic network directly influence investor market expectations. This ratio compares the current market value of INVO Fertility Inc (IVF) to its net asset value. It measures the premium the market is willing to pay for future capitalization growth above the book value. High values signal an overvaluation of the business. By analyzing the dynamics of the market value to book value multiple, one can determine the optimal entry point into the asset.

Competitor analysis

Boston Scientific - Market Value to Book Value Ratio|EW (edwards.com) - Market Capitalization to Book Value|Market Value to Book Value Ratio ResMed RMD|Market Capitalization to Net Assets Insulet Corp|Zimmer Biomet Holdings, Inc. - Market Capitalization to Book Value Ratio|Market-to-Book Ratio CooperSurgical (COO)|Align Technology, Inc. - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio globusmedical.com GMED|Market Capitalization to Book Value Ratio TMDX (TransMedics Group)|ATEC - Market Capitalization to Book Value|AORT: Market Capitalization to Book Value Ratio|ENOV (Enovis Inc.) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Integra LifeSciences|Market Value to Book Value Ratio establishmentlabs.com|BBNX (Beta Bionics) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value IRADIMED Corp IRMD|Embecta Inc. (EMBC) - Market Cap to Net Assets Ratio|Market Capitalization to Net Assets Tandem Corp TNDM|AXGN (AxoGen, Inc.) - Market Capitalization to Book Value Ratio|SIBN - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Orthofix|Capitalization to Book Value Ratio Bioventus Inc|KIDS - Market Cap to Net Assets Ratio|Market Value to Book Value TMCI|Market Value to Book Value Ratio SRTA (Strata Critical Medical Inc)|Market Cap to Net Assets Ratio carlsmed.com (CARL)|RXST: Market Capitalization to Book Value Ratio|Market-to-Book Ratio ClearPoint Neuro Inc. CLPT|Stereotaxis Corp (STXS) - Market Capitalization to Book Value Ratio|STIM - Capitalization to Book Value Ratio|Sight Sciences, Inc. - Market Capitalization to Book Value Ratio|orchestrabiomed.com (OBIO) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio ANIK|Market Cap to Net Assets Ratio InspireMD Inc|Market Capitalization to Book Value Ratio ZJYL|Market Capitalization to Book Value Ratio VANI (vivani.com)|Market Value to Book Value Ratio Xtant Medical XTNT|NMTC - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Modular Med (MODD)|MYO - Market Value to Book Value|Market Capitalization to Book Value Ratio COCH|VVOS (Vivos Therapeutics Inc) - Market-to-Book Ratio|enVVeno Medical - Market Value to Book Value Ratio|Market Value to Equity Ratio SINTX Technologies (SINT)|Market Cap to Net Assets Ratio TNON|Market Capitalization to Book Value Ratio ReWalk Robotics (LFWD)|Market Capitalization to Book Value Ratio AMIX|Bone Biologics Inc - Market Capitalization to Book Value|Market Value to Book Value Ratio Axonics, Inc.|BIOL: Market Capitalization to Net Assets|DYNT (dynatronics.com) - Market Value to Book Value Ratio|Paragon 28 (FNA) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio INVO (INVO Bioscience Inc.)